Skip to main content

Find Clinical Trials

Home
Conditions
DNA Virus Infections

Clinical trial condition

DNA Virus Infections

Explore clinical trials studying DNA Virus Infections. Study availability and eligibility vary by location and protocol.

3,911 public trials 503 recruiting studies

Refine in advanced search Browse all conditions

DNA Virus Infections trial results

Completed

Once Daily Dosing of Lonafarnib Co-administered With Ritonavir for Treatment of Chronic Hepatitis D Virus Infection

NCT05229991

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +16 more
Locations: Soroka UMC Beersheba, Israel

New Zealand Liver Transplant Unit, Auckland City Hospital Auckland, New Zealand

Department of Gastroenterology and Hepatology, Koç University Medical School, Istanbul, Turkey Istanbul, Turkey (Türkiye)

View Trial Details

Completed

Open-Label Study of AB-729, Nucleos(t)Ide Analogue and Pegylated Interferon Alfa-2a in Subjects With Chronic Hepatitis B Infection

NCT04980482

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Arizona Liver Health Chandler, Arizona, United States

Arizona Liver Health Tucson, Arizona, United States

Research and Education, Inc. San Diego, California, United States

University of Miami Miller School of Medicine Miami, Florida, United States

View all 17 locations

View Trial Details

Completed

Anti-CD22 Chimeric Receptor T Cells in Pediatric and Young Adults With Recurrent or Refractory CD22-expressing B Cell Malignancies

NCT02315612

Conditions: ALL, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, +32 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants

NCT02366286

Conditions: Adenocarcinoma, Blood-Borne Infections, Carcinoma, +20 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

JYNNEOS Smallpox Vaccine in Adult Healthcare Personnel at Risk for Mpox in the Democratic Republic of the Congo

NCT02977715

Conditions: Animal Diseases, DNA Virus Infections, Infections, +7 more
Locations: Tshuapa site Boende, Tshuapa, Democratic Republic of the Congo

View Trial Details

Completed

Study of VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects With Chronic Hepatitis B Virus Infection

NCT04856085

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Investigative Site San Francisco, California, United States

Investigative Site Miami, Florida, United States

Investigative Site Orlando, Florida, United States

Investigative Site Baltimore, Maryland, United States

View all 37 locations

View Trial Details

Completed

Trial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-seronegative Persons

NCT05683834

Conditions: DNA Virus Infections, Epstein-Barr Virus Infection, Epstein-Barr Virus Infections, +18 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

Social-environmental, Psychosocial, Behavioral, Clinical and Biological Drivers of Disparities in Liver Disease Progression Among Korean American With Chronic Hepatitis B Infection

NCT05117541

Conditions: Blood-Borne Infections, Chronic Viral Hepatitis, Communicable Diseases, +10 more
Locations: Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Open Multi-cohort Study of the First Phase of Safety of a Drug Based on Double Recombinant Vaccinia Virus VV-GMCSF-Lact

NCT05376527

Conditions: Breast Diseases, Breast Neoplasms, DNA Virus Infections, +9 more
Locations: N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation Moscow, Russia

National Medical Research Radiological Centre (NMRRC) of the Ministry of Health of the Russian Federation Obninsk, Russia

N.N. Petrov National Medical Research Center of Oncology Saint Petersburg, Russia

Oncology Research Center, LLC Saint Petersburg, Russia

View Trial Details

Completed

Study of VIR-2218 With or Without Pegylated Interferon Alpha-2a for Treatment of Chronic Hepatitis B Virus Infection

NCT04412863

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Investigative Site Birtinya, Queensland, Australia

Investigative Site Fitzroy, Victoria, Australia

Investigative site Hong Kong

Investigative Site Batu Caves, Malaysia

View all 22 locations

View Trial Details